Chemical & Material
Tenofovir Disoproxil Fumarate Drug Substance - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Oct 12, 24
- ID: 163178
- Pages: 144
- Figures: 259
- Views: 5
The global market for Tenofovir Disoproxil Fumarate Drug Substance was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tenofovir Disoproxil Fumarate Drug Substance, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tenofovir Disoproxil Fumarate Drug Substance by region & country, by Type, and by Application.
The Tenofovir Disoproxil Fumarate Drug Substance market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tenofovir Disoproxil Fumarate Drug Substance.
Market Segmentation
By Company
MACLEODS PHARMACEUTICALS LTD
HETERO LABS LTD
AUROBINDO PHARMA LTD
MYLAN LABORATORIES LTD
CIPLA LTD
VIYASH LIFE SCIENCES PRIVATE LTD
EMCURE PHARMACEUTICALS LTD
STYRAX PHARMA PRIVATE LTD
LAURUS LABS LTD
AURISCO PHARMACEUTICAL CO LTD
ACEBRIGHT INDIA PHARMA PRIVATE LTD
SOLARA ACTIVE PHARMA SCIENCES LTD
LUPIN LTD
SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD
ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
SHANDONG ANHONG PHARMACEUTICAL CO LTD
JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD
ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
Segment by Type:
Purity≥99%
Purity<99%
Segment by Application
Tablet
Granule
Capsule
Oral Powder
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tenofovir Disoproxil Fumarate Drug Substance manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Tenofovir Disoproxil Fumarate Drug Substance in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Tenofovir Disoproxil Fumarate Drug Substance in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tenofovir Disoproxil Fumarate Drug Substance, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tenofovir Disoproxil Fumarate Drug Substance by region & country, by Type, and by Application.
The Tenofovir Disoproxil Fumarate Drug Substance market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tenofovir Disoproxil Fumarate Drug Substance.
Market Segmentation
By Company
MACLEODS PHARMACEUTICALS LTD
HETERO LABS LTD
AUROBINDO PHARMA LTD
MYLAN LABORATORIES LTD
CIPLA LTD
VIYASH LIFE SCIENCES PRIVATE LTD
EMCURE PHARMACEUTICALS LTD
STYRAX PHARMA PRIVATE LTD
LAURUS LABS LTD
AURISCO PHARMACEUTICAL CO LTD
ACEBRIGHT INDIA PHARMA PRIVATE LTD
SOLARA ACTIVE PHARMA SCIENCES LTD
LUPIN LTD
SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD
ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
SHANDONG ANHONG PHARMACEUTICAL CO LTD
JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD
ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
Segment by Type:
Purity≥99%
Purity<99%
Segment by Application
Tablet
Granule
Capsule
Oral Powder
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tenofovir Disoproxil Fumarate Drug Substance manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Tenofovir Disoproxil Fumarate Drug Substance in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Tenofovir Disoproxil Fumarate Drug Substance in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Tenofovir Disoproxil Fumarate Drug Substance Product Introduction
1.2 Global Tenofovir Disoproxil Fumarate Drug Substance Market Size Forecast
1.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030)
1.2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (2019-2030)
1.2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Price (2019-2030)
1.3 Tenofovir Disoproxil Fumarate Drug Substance Market Trends & Drivers
1.3.1 Tenofovir Disoproxil Fumarate Drug Substance Industry Trends
1.3.2 Tenofovir Disoproxil Fumarate Drug Substance Market Drivers & Opportunity
1.3.3 Tenofovir Disoproxil Fumarate Drug Substance Market Challenges
1.3.4 Tenofovir Disoproxil Fumarate Drug Substance Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Players Revenue Ranking (2023)
2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Revenue by Company (2019-2024)
2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Players Sales Volume Ranking (2023)
2.4 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Company Players (2019-2024)
2.5 Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Company (2019-2024)
2.6 Key Manufacturers Tenofovir Disoproxil Fumarate Drug Substance Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Tenofovir Disoproxil Fumarate Drug Substance Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Tenofovir Disoproxil Fumarate Drug Substance
2.9 Tenofovir Disoproxil Fumarate Drug Substance Market Competitive Analysis
2.9.1 Tenofovir Disoproxil Fumarate Drug Substance Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Tenofovir Disoproxil Fumarate Drug Substance Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenofovir Disoproxil Fumarate Drug Substance as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity≥99%
3.1.2 Purity<99%
3.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type
3.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value, by Type (2019-2030)
3.2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value, by Type (%) (2019-2030)
3.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type
3.3.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, by Type (2019-2030)
3.3.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, by Type (%) (2019-2030)
3.4 Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablet
4.1.2 Granule
4.1.3 Capsule
4.1.4 Oral Powder
4.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application
4.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value, by Application (2019-2030)
4.2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value, by Application (%) (2019-2030)
4.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application
4.3.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, by Application (2019-2030)
4.3.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, by Application (%) (2019-2030)
4.4 Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region
5.1.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2019-2024)
5.1.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2025-2030)
5.1.4 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (%), (2019-2030)
5.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region
5.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2019-2024)
5.2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2025-2030)
5.2.4 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (%), (2019-2030)
5.3 Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
5.4.2 North America Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
5.5.2 Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
5.6.2 Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
5.7.2 South America Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
5.8.2 Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value
6.2.1 Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.2.2 Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.3.2 United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.4.2 Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.5.2 China Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.5.3 China Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.6.2 Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.7.2 South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.8.2 Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.9.2 India Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.9.3 India Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 MACLEODS PHARMACEUTICALS LTD
7.1.1 MACLEODS PHARMACEUTICALS LTD Company Information
7.1.2 MACLEODS PHARMACEUTICALS LTD Introduction and Business Overview
7.1.3 MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.1.4 MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.1.5 MACLEODS PHARMACEUTICALS LTD Recent Development
7.2 HETERO LABS LTD
7.2.1 HETERO LABS LTD Company Information
7.2.2 HETERO LABS LTD Introduction and Business Overview
7.2.3 HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.2.4 HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.2.5 HETERO LABS LTD Recent Development
7.3 AUROBINDO PHARMA LTD
7.3.1 AUROBINDO PHARMA LTD Company Information
7.3.2 AUROBINDO PHARMA LTD Introduction and Business Overview
7.3.3 AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.3.4 AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.3.5 AUROBINDO PHARMA LTD Recent Development
7.4 MYLAN LABORATORIES LTD
7.4.1 MYLAN LABORATORIES LTD Company Information
7.4.2 MYLAN LABORATORIES LTD Introduction and Business Overview
7.4.3 MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.4.4 MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.4.5 MYLAN LABORATORIES LTD Recent Development
7.5 CIPLA LTD
7.5.1 CIPLA LTD Company Information
7.5.2 CIPLA LTD Introduction and Business Overview
7.5.3 CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.5.5 CIPLA LTD Recent Development
7.6 VIYASH LIFE SCIENCES PRIVATE LTD
7.6.1 VIYASH LIFE SCIENCES PRIVATE LTD Company Information
7.6.2 VIYASH LIFE SCIENCES PRIVATE LTD Introduction and Business Overview
7.6.3 VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.6.4 VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.6.5 VIYASH LIFE SCIENCES PRIVATE LTD Recent Development
7.7 EMCURE PHARMACEUTICALS LTD
7.7.1 EMCURE PHARMACEUTICALS LTD Company Information
7.7.2 EMCURE PHARMACEUTICALS LTD Introduction and Business Overview
7.7.3 EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.7.4 EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.7.5 EMCURE PHARMACEUTICALS LTD Recent Development
7.8 STYRAX PHARMA PRIVATE LTD
7.8.1 STYRAX PHARMA PRIVATE LTD Company Information
7.8.2 STYRAX PHARMA PRIVATE LTD Introduction and Business Overview
7.8.3 STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.8.4 STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.8.5 STYRAX PHARMA PRIVATE LTD Recent Development
7.9 LAURUS LABS LTD
7.9.1 LAURUS LABS LTD Company Information
7.9.2 LAURUS LABS LTD Introduction and Business Overview
7.9.3 LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.9.4 LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.9.5 LAURUS LABS LTD Recent Development
7.10 AURISCO PHARMACEUTICAL CO LTD
7.10.1 AURISCO PHARMACEUTICAL CO LTD Company Information
7.10.2 AURISCO PHARMACEUTICAL CO LTD Introduction and Business Overview
7.10.3 AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.10.4 AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.10.5 AURISCO PHARMACEUTICAL CO LTD Recent Development
7.11 ACEBRIGHT INDIA PHARMA PRIVATE LTD
7.11.1 ACEBRIGHT INDIA PHARMA PRIVATE LTD Company Information
7.11.2 ACEBRIGHT INDIA PHARMA PRIVATE LTD Introduction and Business Overview
7.11.3 ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.11.4 ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.11.5 ACEBRIGHT INDIA PHARMA PRIVATE LTD Recent Development
7.12 SOLARA ACTIVE PHARMA SCIENCES LTD
7.12.1 SOLARA ACTIVE PHARMA SCIENCES LTD Company Information
7.12.2 SOLARA ACTIVE PHARMA SCIENCES LTD Introduction and Business Overview
7.12.3 SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.12.4 SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.12.5 SOLARA ACTIVE PHARMA SCIENCES LTD Recent Development
7.13 LUPIN LTD
7.13.1 LUPIN LTD Company Information
7.13.2 LUPIN LTD Introduction and Business Overview
7.13.3 LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.13.4 LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.13.5 LUPIN LTD Recent Development
7.14 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
7.14.1 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Company Information
7.14.2 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Introduction and Business Overview
7.14.3 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.14.4 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.14.5 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Recent Development
7.15 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD
7.15.1 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Company Information
7.15.2 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Introduction and Business Overview
7.15.3 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.15.4 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.15.5 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Recent Development
7.16 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
7.16.1 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Company Information
7.16.2 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Introduction and Business Overview
7.16.3 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.16.4 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.16.5 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Recent Development
7.17 SHANDONG ANHONG PHARMACEUTICAL CO LTD
7.17.1 SHANDONG ANHONG PHARMACEUTICAL CO LTD Company Information
7.17.2 SHANDONG ANHONG PHARMACEUTICAL CO LTD Introduction and Business Overview
7.17.3 SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.17.4 SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.17.5 SHANDONG ANHONG PHARMACEUTICAL CO LTD Recent Development
7.18 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD
7.18.1 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Company Information
7.18.2 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Introduction and Business Overview
7.18.3 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.18.4 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.18.5 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Recent Development
7.19 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
7.19.1 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Company Information
7.19.2 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Introduction and Business Overview
7.19.3 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.19.4 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.19.5 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Recent Development
8 Industry Chain Analysis
8.1 Tenofovir Disoproxil Fumarate Drug Substance Industrial Chain
8.2 Tenofovir Disoproxil Fumarate Drug Substance Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tenofovir Disoproxil Fumarate Drug Substance Sales Model
8.5.2 Sales Channel
8.5.3 Tenofovir Disoproxil Fumarate Drug Substance Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Tenofovir Disoproxil Fumarate Drug Substance Product Introduction
1.2 Global Tenofovir Disoproxil Fumarate Drug Substance Market Size Forecast
1.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030)
1.2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (2019-2030)
1.2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Price (2019-2030)
1.3 Tenofovir Disoproxil Fumarate Drug Substance Market Trends & Drivers
1.3.1 Tenofovir Disoproxil Fumarate Drug Substance Industry Trends
1.3.2 Tenofovir Disoproxil Fumarate Drug Substance Market Drivers & Opportunity
1.3.3 Tenofovir Disoproxil Fumarate Drug Substance Market Challenges
1.3.4 Tenofovir Disoproxil Fumarate Drug Substance Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Players Revenue Ranking (2023)
2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Revenue by Company (2019-2024)
2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Players Sales Volume Ranking (2023)
2.4 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Company Players (2019-2024)
2.5 Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Company (2019-2024)
2.6 Key Manufacturers Tenofovir Disoproxil Fumarate Drug Substance Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Tenofovir Disoproxil Fumarate Drug Substance Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Tenofovir Disoproxil Fumarate Drug Substance
2.9 Tenofovir Disoproxil Fumarate Drug Substance Market Competitive Analysis
2.9.1 Tenofovir Disoproxil Fumarate Drug Substance Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Tenofovir Disoproxil Fumarate Drug Substance Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenofovir Disoproxil Fumarate Drug Substance as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity≥99%
3.1.2 Purity<99%
3.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type
3.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value, by Type (2019-2030)
3.2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value, by Type (%) (2019-2030)
3.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type
3.3.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, by Type (2019-2030)
3.3.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, by Type (%) (2019-2030)
3.4 Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablet
4.1.2 Granule
4.1.3 Capsule
4.1.4 Oral Powder
4.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application
4.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value, by Application (2019-2030)
4.2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value, by Application (%) (2019-2030)
4.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application
4.3.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, by Application (2019-2030)
4.3.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, by Application (%) (2019-2030)
4.4 Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region
5.1.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2019-2024)
5.1.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2025-2030)
5.1.4 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (%), (2019-2030)
5.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region
5.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2019-2024)
5.2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2025-2030)
5.2.4 Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (%), (2019-2030)
5.3 Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
5.4.2 North America Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
5.5.2 Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
5.6.2 Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
5.7.2 South America Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
5.8.2 Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value
6.2.1 Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.2.2 Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.3.2 United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.4.2 Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.5.2 China Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.5.3 China Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.6.2 Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.7.2 South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.8.2 Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019-2030
6.9.2 India Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
6.9.3 India Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 MACLEODS PHARMACEUTICALS LTD
7.1.1 MACLEODS PHARMACEUTICALS LTD Company Information
7.1.2 MACLEODS PHARMACEUTICALS LTD Introduction and Business Overview
7.1.3 MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.1.4 MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.1.5 MACLEODS PHARMACEUTICALS LTD Recent Development
7.2 HETERO LABS LTD
7.2.1 HETERO LABS LTD Company Information
7.2.2 HETERO LABS LTD Introduction and Business Overview
7.2.3 HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.2.4 HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.2.5 HETERO LABS LTD Recent Development
7.3 AUROBINDO PHARMA LTD
7.3.1 AUROBINDO PHARMA LTD Company Information
7.3.2 AUROBINDO PHARMA LTD Introduction and Business Overview
7.3.3 AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.3.4 AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.3.5 AUROBINDO PHARMA LTD Recent Development
7.4 MYLAN LABORATORIES LTD
7.4.1 MYLAN LABORATORIES LTD Company Information
7.4.2 MYLAN LABORATORIES LTD Introduction and Business Overview
7.4.3 MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.4.4 MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.4.5 MYLAN LABORATORIES LTD Recent Development
7.5 CIPLA LTD
7.5.1 CIPLA LTD Company Information
7.5.2 CIPLA LTD Introduction and Business Overview
7.5.3 CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.5.5 CIPLA LTD Recent Development
7.6 VIYASH LIFE SCIENCES PRIVATE LTD
7.6.1 VIYASH LIFE SCIENCES PRIVATE LTD Company Information
7.6.2 VIYASH LIFE SCIENCES PRIVATE LTD Introduction and Business Overview
7.6.3 VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.6.4 VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.6.5 VIYASH LIFE SCIENCES PRIVATE LTD Recent Development
7.7 EMCURE PHARMACEUTICALS LTD
7.7.1 EMCURE PHARMACEUTICALS LTD Company Information
7.7.2 EMCURE PHARMACEUTICALS LTD Introduction and Business Overview
7.7.3 EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.7.4 EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.7.5 EMCURE PHARMACEUTICALS LTD Recent Development
7.8 STYRAX PHARMA PRIVATE LTD
7.8.1 STYRAX PHARMA PRIVATE LTD Company Information
7.8.2 STYRAX PHARMA PRIVATE LTD Introduction and Business Overview
7.8.3 STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.8.4 STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.8.5 STYRAX PHARMA PRIVATE LTD Recent Development
7.9 LAURUS LABS LTD
7.9.1 LAURUS LABS LTD Company Information
7.9.2 LAURUS LABS LTD Introduction and Business Overview
7.9.3 LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.9.4 LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.9.5 LAURUS LABS LTD Recent Development
7.10 AURISCO PHARMACEUTICAL CO LTD
7.10.1 AURISCO PHARMACEUTICAL CO LTD Company Information
7.10.2 AURISCO PHARMACEUTICAL CO LTD Introduction and Business Overview
7.10.3 AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.10.4 AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.10.5 AURISCO PHARMACEUTICAL CO LTD Recent Development
7.11 ACEBRIGHT INDIA PHARMA PRIVATE LTD
7.11.1 ACEBRIGHT INDIA PHARMA PRIVATE LTD Company Information
7.11.2 ACEBRIGHT INDIA PHARMA PRIVATE LTD Introduction and Business Overview
7.11.3 ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.11.4 ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.11.5 ACEBRIGHT INDIA PHARMA PRIVATE LTD Recent Development
7.12 SOLARA ACTIVE PHARMA SCIENCES LTD
7.12.1 SOLARA ACTIVE PHARMA SCIENCES LTD Company Information
7.12.2 SOLARA ACTIVE PHARMA SCIENCES LTD Introduction and Business Overview
7.12.3 SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.12.4 SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.12.5 SOLARA ACTIVE PHARMA SCIENCES LTD Recent Development
7.13 LUPIN LTD
7.13.1 LUPIN LTD Company Information
7.13.2 LUPIN LTD Introduction and Business Overview
7.13.3 LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.13.4 LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.13.5 LUPIN LTD Recent Development
7.14 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
7.14.1 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Company Information
7.14.2 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Introduction and Business Overview
7.14.3 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.14.4 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.14.5 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Recent Development
7.15 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD
7.15.1 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Company Information
7.15.2 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Introduction and Business Overview
7.15.3 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.15.4 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.15.5 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Recent Development
7.16 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
7.16.1 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Company Information
7.16.2 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Introduction and Business Overview
7.16.3 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.16.4 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.16.5 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Recent Development
7.17 SHANDONG ANHONG PHARMACEUTICAL CO LTD
7.17.1 SHANDONG ANHONG PHARMACEUTICAL CO LTD Company Information
7.17.2 SHANDONG ANHONG PHARMACEUTICAL CO LTD Introduction and Business Overview
7.17.3 SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.17.4 SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.17.5 SHANDONG ANHONG PHARMACEUTICAL CO LTD Recent Development
7.18 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD
7.18.1 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Company Information
7.18.2 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Introduction and Business Overview
7.18.3 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.18.4 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.18.5 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Recent Development
7.19 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
7.19.1 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Company Information
7.19.2 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Introduction and Business Overview
7.19.3 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales, Revenue and Gross Margin (2019-2024)
7.19.4 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
7.19.5 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Recent Development
8 Industry Chain Analysis
8.1 Tenofovir Disoproxil Fumarate Drug Substance Industrial Chain
8.2 Tenofovir Disoproxil Fumarate Drug Substance Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tenofovir Disoproxil Fumarate Drug Substance Sales Model
8.5.2 Sales Channel
8.5.3 Tenofovir Disoproxil Fumarate Drug Substance Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Tenofovir Disoproxil Fumarate Drug Substance Market Trends
Table 2. Tenofovir Disoproxil Fumarate Drug Substance Market Drivers & Opportunity
Table 3. Tenofovir Disoproxil Fumarate Drug Substance Market Challenges
Table 4. Tenofovir Disoproxil Fumarate Drug Substance Market Restraints
Table 5. Global Tenofovir Disoproxil Fumarate Drug Substance Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share by Company (2019-2024)
Table 7. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Company (2019-2024) & (Tons)
Table 8. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Tenofovir Disoproxil Fumarate Drug Substance Price by Company (2019-2024) & (US$/Ton)
Table 10. Key Manufacturers Tenofovir Disoproxil Fumarate Drug Substance Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Tenofovir Disoproxil Fumarate Drug Substance Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Tenofovir Disoproxil Fumarate Drug Substance
Table 13. Global Tenofovir Disoproxil Fumarate Drug Substance Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenofovir Disoproxil Fumarate Drug Substance as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
Table 22. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type (2019-2024) & (Tons)
Table 23. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type (2025-2030) & (Tons)
Table 24. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Type (2019-2024) & (US$/Ton)
Table 27. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Type (2025-2030) & (US$/Ton)
Table 28. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
Table 34. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application (2019-2024) & (Tons)
Table 35. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application (2025-2030) & (Tons)
Table 36. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Application (2019-2024) & (US$/Ton)
Table 39. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Application (2025-2030) & (US$/Ton)
Table 40. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2019-2024) & (%)
Table 44. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2025-2030) & (%)
Table 45. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
Table 46. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2019-2024) & (Tons)
Table 47. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2025-2030) & (Tons)
Table 48. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2019-2024) & (%)
Table 49. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2025-2030) & (%)
Table 50. Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Region (2019-2024) & (US$/Ton)
Table 51. Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Region (2025-2030) & (US$/Ton)
Table 52. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, (2019-2024) & (Tons)
Table 56. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, (2025-2030) & (Tons)
Table 57. MACLEODS PHARMACEUTICALS LTD Company Information
Table 58. MACLEODS PHARMACEUTICALS LTD Introduction and Business Overview
Table 59. MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 60. MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 61. MACLEODS PHARMACEUTICALS LTD Recent Development
Table 62. HETERO LABS LTD Company Information
Table 63. HETERO LABS LTD Introduction and Business Overview
Table 64. HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 65. HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 66. HETERO LABS LTD Recent Development
Table 67. AUROBINDO PHARMA LTD Company Information
Table 68. AUROBINDO PHARMA LTD Introduction and Business Overview
Table 69. AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 70. AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 71. AUROBINDO PHARMA LTD Recent Development
Table 72. MYLAN LABORATORIES LTD Company Information
Table 73. MYLAN LABORATORIES LTD Introduction and Business Overview
Table 74. MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 76. MYLAN LABORATORIES LTD Recent Development
Table 77. CIPLA LTD Company Information
Table 78. CIPLA LTD Introduction and Business Overview
Table 79. CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 81. CIPLA LTD Recent Development
Table 82. VIYASH LIFE SCIENCES PRIVATE LTD Company Information
Table 83. VIYASH LIFE SCIENCES PRIVATE LTD Introduction and Business Overview
Table 84. VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 86. VIYASH LIFE SCIENCES PRIVATE LTD Recent Development
Table 87. EMCURE PHARMACEUTICALS LTD Company Information
Table 88. EMCURE PHARMACEUTICALS LTD Introduction and Business Overview
Table 89. EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 91. EMCURE PHARMACEUTICALS LTD Recent Development
Table 92. STYRAX PHARMA PRIVATE LTD Company Information
Table 93. STYRAX PHARMA PRIVATE LTD Introduction and Business Overview
Table 94. STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 96. STYRAX PHARMA PRIVATE LTD Recent Development
Table 97. LAURUS LABS LTD Company Information
Table 98. LAURUS LABS LTD Introduction and Business Overview
Table 99. LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 101. LAURUS LABS LTD Recent Development
Table 102. AURISCO PHARMACEUTICAL CO LTD Company Information
Table 103. AURISCO PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 104. AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 106. AURISCO PHARMACEUTICAL CO LTD Recent Development
Table 107. ACEBRIGHT INDIA PHARMA PRIVATE LTD Company Information
Table 108. ACEBRIGHT INDIA PHARMA PRIVATE LTD Introduction and Business Overview
Table 109. ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 110. ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 111. ACEBRIGHT INDIA PHARMA PRIVATE LTD Recent Development
Table 112. SOLARA ACTIVE PHARMA SCIENCES LTD Company Information
Table 113. SOLARA ACTIVE PHARMA SCIENCES LTD Introduction and Business Overview
Table 114. SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 115. SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 116. SOLARA ACTIVE PHARMA SCIENCES LTD Recent Development
Table 117. LUPIN LTD Company Information
Table 118. LUPIN LTD Introduction and Business Overview
Table 119. LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 120. LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 121. LUPIN LTD Recent Development
Table 122. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Company Information
Table 123. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 124. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 125. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 126. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Recent Development
Table 127. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Company Information
Table 128. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 129. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 130. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 131. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Recent Development
Table 132. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Company Information
Table 133. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Introduction and Business Overview
Table 134. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 135. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 136. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Recent Development
Table 137. SHANDONG ANHONG PHARMACEUTICAL CO LTD Company Information
Table 138. SHANDONG ANHONG PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 139. SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 140. SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 141. SHANDONG ANHONG PHARMACEUTICAL CO LTD Recent Development
Table 142. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Company Information
Table 143. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Introduction and Business Overview
Table 144. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 145. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 146. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Recent Development
Table 147. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Company Information
Table 148. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 149. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 150. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 151. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Tenofovir Disoproxil Fumarate Drug Substance Downstream Customers
Table 155. Tenofovir Disoproxil Fumarate Drug Substance Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Tenofovir Disoproxil Fumarate Drug Substance Product Picture
Figure 2. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (2019-2030) & (Tons)
Figure 5. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Price (2019-2030) & (US$/Ton)
Figure 6. Tenofovir Disoproxil Fumarate Drug Substance Report Years Considered
Figure 7. Global Tenofovir Disoproxil Fumarate Drug Substance Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Tenofovir Disoproxil Fumarate Drug Substance Players Sales Volume Ranking (2023) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tenofovir Disoproxil Fumarate Drug Substance Revenue in 2023
Figure 10. Tenofovir Disoproxil Fumarate Drug Substance Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Purity≥99% Picture
Figure 12. Purity<99% Picture
Figure 13. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
Figure 16. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Type (2019-2030) & (US$/Ton)
Figure 18. Product Picture of Tablet
Figure 19. Product Picture of Granule
Figure 20. Product Picture of Capsule
Figure 21. Product Picture of Oral Powder
Figure 22. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 25. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Application (2019-2030) & (US$/Ton)
Figure 27. North America Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (%), (2019-2030)
Figure 39. United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 45. China Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 47. China Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 57. India Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 59. India Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 60. Tenofovir Disoproxil Fumarate Drug Substance Industrial Chain
Figure 61. Tenofovir Disoproxil Fumarate Drug Substance Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Tenofovir Disoproxil Fumarate Drug Substance Market Trends
Table 2. Tenofovir Disoproxil Fumarate Drug Substance Market Drivers & Opportunity
Table 3. Tenofovir Disoproxil Fumarate Drug Substance Market Challenges
Table 4. Tenofovir Disoproxil Fumarate Drug Substance Market Restraints
Table 5. Global Tenofovir Disoproxil Fumarate Drug Substance Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Tenofovir Disoproxil Fumarate Drug Substance Revenue Market Share by Company (2019-2024)
Table 7. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Company (2019-2024) & (Tons)
Table 8. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Tenofovir Disoproxil Fumarate Drug Substance Price by Company (2019-2024) & (US$/Ton)
Table 10. Key Manufacturers Tenofovir Disoproxil Fumarate Drug Substance Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Tenofovir Disoproxil Fumarate Drug Substance Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Tenofovir Disoproxil Fumarate Drug Substance
Table 13. Global Tenofovir Disoproxil Fumarate Drug Substance Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenofovir Disoproxil Fumarate Drug Substance as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
Table 22. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type (2019-2024) & (Tons)
Table 23. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type (2025-2030) & (Tons)
Table 24. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Type (2019-2024) & (US$/Ton)
Table 27. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Type (2025-2030) & (US$/Ton)
Table 28. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
Table 34. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application (2019-2024) & (Tons)
Table 35. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application (2025-2030) & (Tons)
Table 36. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Application (2019-2024) & (US$/Ton)
Table 39. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Application (2025-2030) & (US$/Ton)
Table 40. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2019-2024) & (%)
Table 44. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Region (2025-2030) & (%)
Table 45. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
Table 46. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2019-2024) & (Tons)
Table 47. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2025-2030) & (Tons)
Table 48. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2019-2024) & (%)
Table 49. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Region (2025-2030) & (%)
Table 50. Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Region (2019-2024) & (US$/Ton)
Table 51. Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Region (2025-2030) & (US$/Ton)
Table 52. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, (2019-2024) & (Tons)
Table 56. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Volume, (2025-2030) & (Tons)
Table 57. MACLEODS PHARMACEUTICALS LTD Company Information
Table 58. MACLEODS PHARMACEUTICALS LTD Introduction and Business Overview
Table 59. MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 60. MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 61. MACLEODS PHARMACEUTICALS LTD Recent Development
Table 62. HETERO LABS LTD Company Information
Table 63. HETERO LABS LTD Introduction and Business Overview
Table 64. HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 65. HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 66. HETERO LABS LTD Recent Development
Table 67. AUROBINDO PHARMA LTD Company Information
Table 68. AUROBINDO PHARMA LTD Introduction and Business Overview
Table 69. AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 70. AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 71. AUROBINDO PHARMA LTD Recent Development
Table 72. MYLAN LABORATORIES LTD Company Information
Table 73. MYLAN LABORATORIES LTD Introduction and Business Overview
Table 74. MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 76. MYLAN LABORATORIES LTD Recent Development
Table 77. CIPLA LTD Company Information
Table 78. CIPLA LTD Introduction and Business Overview
Table 79. CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 81. CIPLA LTD Recent Development
Table 82. VIYASH LIFE SCIENCES PRIVATE LTD Company Information
Table 83. VIYASH LIFE SCIENCES PRIVATE LTD Introduction and Business Overview
Table 84. VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 86. VIYASH LIFE SCIENCES PRIVATE LTD Recent Development
Table 87. EMCURE PHARMACEUTICALS LTD Company Information
Table 88. EMCURE PHARMACEUTICALS LTD Introduction and Business Overview
Table 89. EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 91. EMCURE PHARMACEUTICALS LTD Recent Development
Table 92. STYRAX PHARMA PRIVATE LTD Company Information
Table 93. STYRAX PHARMA PRIVATE LTD Introduction and Business Overview
Table 94. STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 96. STYRAX PHARMA PRIVATE LTD Recent Development
Table 97. LAURUS LABS LTD Company Information
Table 98. LAURUS LABS LTD Introduction and Business Overview
Table 99. LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 101. LAURUS LABS LTD Recent Development
Table 102. AURISCO PHARMACEUTICAL CO LTD Company Information
Table 103. AURISCO PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 104. AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 106. AURISCO PHARMACEUTICAL CO LTD Recent Development
Table 107. ACEBRIGHT INDIA PHARMA PRIVATE LTD Company Information
Table 108. ACEBRIGHT INDIA PHARMA PRIVATE LTD Introduction and Business Overview
Table 109. ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 110. ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 111. ACEBRIGHT INDIA PHARMA PRIVATE LTD Recent Development
Table 112. SOLARA ACTIVE PHARMA SCIENCES LTD Company Information
Table 113. SOLARA ACTIVE PHARMA SCIENCES LTD Introduction and Business Overview
Table 114. SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 115. SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 116. SOLARA ACTIVE PHARMA SCIENCES LTD Recent Development
Table 117. LUPIN LTD Company Information
Table 118. LUPIN LTD Introduction and Business Overview
Table 119. LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 120. LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 121. LUPIN LTD Recent Development
Table 122. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Company Information
Table 123. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 124. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 125. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 126. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Recent Development
Table 127. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Company Information
Table 128. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 129. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 130. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 131. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Recent Development
Table 132. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Company Information
Table 133. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Introduction and Business Overview
Table 134. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 135. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 136. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Recent Development
Table 137. SHANDONG ANHONG PHARMACEUTICAL CO LTD Company Information
Table 138. SHANDONG ANHONG PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 139. SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 140. SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 141. SHANDONG ANHONG PHARMACEUTICAL CO LTD Recent Development
Table 142. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Company Information
Table 143. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Introduction and Business Overview
Table 144. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 145. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 146. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Recent Development
Table 147. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Company Information
Table 148. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 149. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 150. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Offerings
Table 151. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Tenofovir Disoproxil Fumarate Drug Substance Downstream Customers
Table 155. Tenofovir Disoproxil Fumarate Drug Substance Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Tenofovir Disoproxil Fumarate Drug Substance Product Picture
Figure 2. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (2019-2030) & (Tons)
Figure 5. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Price (2019-2030) & (US$/Ton)
Figure 6. Tenofovir Disoproxil Fumarate Drug Substance Report Years Considered
Figure 7. Global Tenofovir Disoproxil Fumarate Drug Substance Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Tenofovir Disoproxil Fumarate Drug Substance Players Sales Volume Ranking (2023) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tenofovir Disoproxil Fumarate Drug Substance Revenue in 2023
Figure 10. Tenofovir Disoproxil Fumarate Drug Substance Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Purity≥99% Picture
Figure 12. Purity<99% Picture
Figure 13. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
Figure 16. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Type (2019-2030) & (US$/Ton)
Figure 18. Product Picture of Tablet
Figure 19. Product Picture of Granule
Figure 20. Product Picture of Capsule
Figure 21. Product Picture of Oral Powder
Figure 22. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 25. Global Tenofovir Disoproxil Fumarate Drug Substance Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Tenofovir Disoproxil Fumarate Drug Substance Price by Application (2019-2030) & (US$/Ton)
Figure 27. North America Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Tenofovir Disoproxil Fumarate Drug Substance Sales Volume (%), (2019-2030)
Figure 39. United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 45. China Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 47. China Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 57. India Tenofovir Disoproxil Fumarate Drug Substance Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Type (%), 2023 VS 2030
Figure 59. India Tenofovir Disoproxil Fumarate Drug Substance Sales Value by Application (%), 2023 VS 2030
Figure 60. Tenofovir Disoproxil Fumarate Drug Substance Industrial Chain
Figure 61. Tenofovir Disoproxil Fumarate Drug Substance Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Digital Multifunction Meter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oct 12, 24
Whole Current Energy Meter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oct 12, 24
High Current Air Circuit Breaker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oct 12, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232